On 25 June, we were proud to exhibit at SMI.London 2025, held at the Pullman London St Pancras—the world’s only conference dedicated exclusively to Soft Mist Inhalers (SMIs). It was a dynamic, well-organised event, and we’d like to thank everyone who stopped by to speak with us.
We truly enjoyed connecting with fellow innovators in the pharmaceutical space and sharing how our extractables and leachables (E&L) and analytical testing services support product development and regulatory compliance.
As one of the event sponsors, we were pleased to contribute to a day full of insight and collaboration. Special thanks to MERXIN for delivering such a valuable programme.
SMI.London 2025 showed just how far Soft Mist Inhalers have come—moving beyond asthma and COPD into exciting areas like lung cancer, GLP-1 treatments, vaccination and pulmonary hypertension. As these therapies evolve, our specialist testing services are here to help developers meet regulatory demands and bring safe, effective products to market.
Contact us at info@rubberconsultants.com to discuss your testing requirements.
